The financial incentives were enormous: GLP-1 medications generated billions annually, creating powerful motivation to increase prescriptions rather than conduct thorough safety investigations or provide complete risk disclosures
SY: Conceptualization, Data curation, Investigation, Methodology, Writing original draft, Writing review & editing
If you are ready to take the next step toward a healthier, happier you, consider exploring GLP-1 treatments at Rejuvenate Wellness and Med Spa, where our team of experts can guide you on your weight loss journey
Tesamorelin is an FDA-approved prescription drug (brand name Egrifta), cleared in 2010 on the strength of multiple Phase 3 double-blind, placebo-controlled randomized trials for a specific, narrow indication: reducing excess abdominal fat in people with HIV-associated lipodystrophy